Intersectin 1 (ITSN1) is a scaffold protein that regulates diverse cellular pathways, including endocytosis and several signal transduction pathways, including phosphatidylinositol 3-kinase, Class IIb (PI3K-C2b). ITSN1's transforming potential in vitro suggests that this scaffold protein may be involved in human tumorigenesis. Herein, we demonstrate that ITSN1 is expressed in primary human neuroblastoma tumors and tumor cell lines and is necessary for their in vitro and in vivo tumorigenic properties. Silencing ITSN1 significantly inhibits the anchorage independent growth of tumor cells in vitro and tumor formation in xenograft assays independent of MYCN status. Overexpression of the ITSN1 target, PI3K-C2b, rescues the soft agar growth of ITSN1-silenced cells demonstrating the importance of the ITSN1-PI3K-C2b pathway in neuroblastoma tumorigenesis. These findings represent the first demonstration that the ITSN1-PI3K-C2b pathway has a requisite role in human cancer, specifically neuroblastomas.
INTRODUCTION
Neuroblastoma (NB) is a malignant tumor that derives from the neural crest and is responsible for 13% of cancer related deaths in children. 1 Although the underlying molecular causes for NB development remains unresolved, a number of molecular changes are associated with tumor progression and disease prognosis, including amplification and overexpression of the MYCN oncogene, increased activation of receptor tyrosine kinases such as ALK and TRKB, chromosome deletion, oncogene activation and tumor suppressor loss (reviewed in Brodeur 2 ). The phosphoinositide 3-kinase (PI3K) family of lipid kinases has been identified as a potential target for NB tumor treatment. 3, 4 Inhibition of PI3Ks by pan-inhibitors block malignant progression in vivo; 3 however, these inhibitors blocks all PI3Ks causing serious toxic effects, thereby limiting their promise for use in NB treatment. The role of PI3Ks in NB tumorigenesis has been associated with their ability to stabilize the MYCN oncogenic transcription factor that is amplified in 25% of NB patients. 5 Emerging data implicate different PI3K isoforms in NBs through stabilization of MYCN oncoprotein. 3, 6, 7 PI3Ks represent a family of lipid kinases that phosphorylate the 3 0 position of phosphatidylinositol. This family consists of three distinct classes based on sequence homology. Class I PI3Ks have garnered significant attention due to the presence of specific activating mutations in human cancers resulting in the effort to develop specific Class IA isoform-specific inhibitors as therapeutics. 8 The role of Class II PI3Ks in human cancers is less clear due to the lack of identified mutations in this family of enzymes. However, PI3K Class IIb (PI3K-C2b) expression is upregulated in a number of cancers 9 --11 and overexpression of PI3K-C2b leads to in vitro transformation of colonic epithelia cells. 12 Furthermore, PI3K-C2b regulates cell survival signaling both in adherent cells 13, 14 and in suspension, 15 which may aid in the survival of metastatic cells once they migrate from the primary tumor site.
Intersectin 1 (ITSN1) is a multi-domain scaffold protein encoded by two major splice products. Both ITSN1-short (ITSN1-S) and ITSN1-long (ITSN1-L) possess two NH 2 -terminal Eps15 homology domains followed by a coiled-coil domain and five Src homology 3 (SH3) domains. These domains allow ITSN1 to interact with a multitude of partners to regulate endocytosis and a variety of signal transduction pathways (reviewed in O'Bryan 16 ). ITSN1-L possesses an extended COOH-terminus encoding a guanine nucleotide exchange factor (GEF) domain specific for Cdc42, a member of the Rho subfamily of Ras-like GTP-ases. 17, 18 ITSN-L is specifically expressed in neurons, whereas ITSN1-S is more widely expressed in multiple cell types. Overexpression of ITSN1 promotes transformation of rodent fibroblasts suggesting that this scaffold may have a role in cancer development. 19, 20 Furthermore, ITSN1 regulates the compartmentalized activation of the Ras protooncogene further supporting a potential role for this scaffold in human tumorigenesis. 21 We discovered that ITSN1 interacts with PI3K-C2b and regulates its activation in the N1E-115 mouse NB cell line. 13 However, the role of this ITSN1-PI3K-C2b pathway in cancer has not been explored.
We previously demonstrated that ITSN1 silencing reduced survival of N1E-115 cells during differentiation and that overexpression of PI3K-C2b or AKT was sufficient to rescue survival of these ITSN1-silenced cells suggesting that the ITSN1-PI3K-C2b pathway has an important role in cell survival during differentiation. 13 However, the involvement of ITSN1 in NB tumorigenesis was not explored. Given ITSN's ability to induce transformation of rodent fibroblasts, we have examined whether the ITSN1-PI3K-C2b pathway regulates the tumorigenic properties of human NBs. Herein, we demonstrate that ITSN1-S and PI3K-C2b are expressed in primary human NB tumors, as well as NB tumor cell lines and that silencing of ITSN1 in NB cell lines reduces their anchorage independent growth in vitro and tumor growth in a xenograft model in vivo. Finally, we demonstrate that overexpression of PI3K-C2b rescues the soft agar growth of ITSN1-silenced NB cells suggesting that PI3K-C2b functions downstream of ITSN1 to regulate the tumorigenic properties of NB cells.
RESULTS
ITSN and PI3K-C2b are expressed in human NB cell lines and primary tumors ITSN1 regulates survival during differentiation of mouse N1E-115 NB line through activation of PI3K-C2b. 13 Although ITSN1 is expressed as both a long and short isoform (ITSN1-L and ITSN1-S, respectively) with the long isoform predominant in neurons, 16, 22 ITSN1-S is sufficient to regulate this survival pathway in N1E-115 cells. Furthermore, ITSN1-S activates the Ras proto-oncogene in a compartmentalized specific manner. 21 Given the importance of Ras in oncogenic transformation coupled with ITSN1's transforming activity in rodent fibroblasts in vitro, 19, 20 we sought to examine whether ITSN1 might also have an important biological role in human NB tumors. Western blot analysis of human NB lines revealed significant expression of ITSN1-S in both MYCN-amplified (MYCN þ ; includes NLF, LAN-1, IMR-5, CHP-134) and nonamplified (MYCNÀ; includes NB-69, SH-SY5Y, SK-N-AS) cells ( Figure 1 ). Although ITSN1-S is the predominant isoform expressed in this panel of NB cells, ITSN1-L is expressed at significant levels in LAN2, LAN5 and IMR-32 cells (data not shown). Analysis of PI3K isoform expression revealed high levels of PI3K-C2b, whereas the well-studied PI3K-C1a (p110) isoform was expressed at more varied levels ( Figure 1a ). As NB lines are invariably derived from high-grade tumors, we examined the expression of ITSN1 and PI3K-C2b in primary human NB tumor samples of differing clinical stages (Figure 1b) . Ten of the eleven tumors expressed levels of ITSN1-S equivalent to or higher than levels observed in CHP-134 NB cell line. The acute promyelocytic leukemia cell line HL-60 does not express ITSN1 and was included as a negative control for comparison.
ITSN1 regulates anchorage-independent growth of NB cells Given ITSN1's expression in NB cells coupled with its transforming activity in rodent fibroblasts, 19, 20 we examined the effect of ITSN1 silencing on the tumorigenic properties of both MYCN þ and MYCNÀ human NBs. Western blot analysis of polyclonal populations both CHP-134 (MYCN þ ) and SK-N-AS (MYCNÀ) lines stably infected with retrovirus encoding specific short hairpin RNAs (shRNAs) revealed that two independent ITSN1-specific shRNAs (sh#1 and 2) reduced ITSN1 expression by 490% compared with control cell lines infected with virus generated from empty vector (pSR) or expressing a scrambled shRNA (pSCR; Figure 2a ). Similar results were obtained with two additional NB lines, IMR-5 (MYCN þ ) and NLF (MYCN þ ; Supplementary Figure  S1A ). ITSN1 silencing did not affect the proliferation or viability of these NB cells compared with controls ( Figure 2b and Supplementary Figure S1B ). Although silencing ITSN1 in neurons and endothelial cells results in increased apoptosis, 13, 23 we did not observe any increase in apoptosis ITSN1-silenced NB cell lines grown under anchorage-independent conditions (Supplementary Figure S1C) . We next assessed whether ITSN1-silencing altered the anchorage-independent growth of the NB lines in soft agar assays. Strikingly, ITSN1-silencing reduced the anchorage-independent growth of NBs by 470% compared with control lines in three of the four lines examined (Figures 3a, b and Supplementary Figure  S2A , B). Furthermore, overexpression of ITSN1-S in parental NB cells enhanced soft agar growth by 2.5-fold compared with control cells (Figures 3c--e) . These data reveal that ITSN1 is an important component in the anchorage-independent growth of NB cells.
ITSN1-silencing did not alter the endocytic process One function of ITSN1 is to regulate the process of endocytosis. 24, 25 Given the link between endocytosis and oncogenesis, 26, 27 we next tested whether the inhibition of soft agar growth of ITSN1-silenced NB cells was due to defects in endocytosis. Similar to our previous results in N1E-115 cells, 13 ITSN1 depletion in human NBs did not alter transferrin internalization ( Figure 4 ).
ITSN-silencing reduced tumor growth in vivo
On the basis of the soft agar data, we next assessed whether ITSN1 was important for tumorigenic properties of NB cells in vivo. 
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ITSN1 acts as an oncogene in neuroblastomas
Interestingly, those tumors that emerged from injection of ITSN1-silenced cells appear to re-express ITSN1. These observations further support the notion that ITSN1 is indeed necessary for tumor growth in vivo. There did not appear to be any consistent changes in PI3K-C2b levels. In sum, ITSN1 silencing reduced the tumorigenic growth of three out of four human NB cell lines strongly suggesting that ITSN1 is important for the tumorigenic potential of NB cells.
PI3K-C2bb overexpression rescues anchorage-independent growth of ITSN-silenced NB cells PI3K-C2b binds ITSN1 and mediates survival elicited by ITSN1 during neuronal differentiation. 13 Thus, we tested whether PI3K-C2b might also mediate ITSN1's role in human NB tumorigenesis. CFP-tagged PI3K-C2b was stably overexpressed in ITSN1-silenced cells (Figure 6a ) and the resulting stable cell line used in a soft agar assay to assess effects on anchorage-independent growth. Interestingly, CFP-PI3K-C2b overexpression rescued anchorageindependent growth of ITSN1-depleted NB cells (Figure 6b) . Consistent with the ITSN1 silencing results, overexpression of PI3K-C2b did not alter growth of adherent cells (Figure 6c ). DISCUSSION ITSN1 is highly expressed in the central nervous system with neurons expressing mainly ITSN1-L and little to no ITSN1-S. Interestingly, NB tumors present the opposite pattern of expression where ITSN1-S predominates with ITSN1-L at much reduced levels. However, several of the tumors do express ITSN1-L with at least one of these tumors expressing similar levels of both isoforms (Figure 1b) . Given the ability of ITSN1 to induce oncogenic transformation, 19, 20 these findings suggest that ITSN1 may have a role in NB tumorigenesis. Although oncogenic mutations have not been described for ITSN1, examination of gene expression databases reveals a potential involvement of ITSN1 in several cancers. The ONCOMINE database indicates that ITSN1 message is overexpressed in pancreatic, lung, liposarcomas, and Wilm's tumor. Several public databases available through the Oncogenomic website (http://pob.abcc.ncifcrf.gov/cgi-bin/JK) indicate that ITSN1 message is overexpressed in NBs and that ITSN1 expression (either ITSN1-S or ITSN1-L) predicts for poor prognosis in high risk NB patients. 28, 29 Indeed, our study demonstrates for the first time that ITSN1-S is required for anchorage-independent growth of NBs both in vitro in soft agar assays and in vivo in xenograft assays. Furthermore, recent reports demonstrate an important role for ITSN1 in the in vivo tumor growth of gliomas. 30, 31 These findings coupled with our results suggest that ITSN1 may have a more general role in human tumorigenesis. Interestingly, neither ITSN1 silencing nor PI3K-C2b overexpression affects the growth of adherent cells or survival of cells in suspension indicating that the ITSN1-PI3K-C2b pathway may specifically regulate growth of tumor cells in suspension. These observations suggest that ITSN1 may be involved in the process of tumor colonization of distant organs.
Somatic mutations in Class I PI3K (PIK3CA) are found in a number of cancers, whereas mutations in the remaining seven PI3K isoforms have not been identified thus far (reviewed in ref. 32 ). PI3K-C2b overexpression, however, rescues anchorage-independent growth of ITSN1-depleted cells suggesting that PI3K-C2b may mediate ITSN1's role in tumorigenesis. Indeed, several lines of evidence suggest a role for PI3K-C2b in cancer. Single-nucleotide polymorphisms in the promoter region of PI3K-C2b are associated with increased risk for prostate cancer suggesting enhanced expression of the protein in these cancers. 33 Overexpression of PI3K-C2b in colonic epithelial cells results in oncogenic transformation. 12 Furthermore, several microarray studies suggest that PI3K-C2b is upregulated in a variety of cancers, including mixed lineage leukemias , 11 a subset of acute myeloid leukemias, 9 and pancreatic cancers. 10 As noted earlier, ITSN1 has also been reported to be overexpressed in pancreatic cancers suggesting that upregulation of the ITSN1-PI3K-C2b signaling pathway may have an important role in pancreatic cancers as well.
Although both ITSN1-S and ITSN1-L are expressed in primary NB tumors and NB cell lines, ITSN1-S is the predominant isoform in these samples. ITSN1 acts as an oncogene in neuroblastomas A Russo and JP O'Bryan two isoforms is not clear. ITSN1-L possesses all the domains present in ITSN1-S in addition to an extended COOH-terminus encoding a GEF specific for Cdc42 resulting in unique functions for ITSN1-L versus ITSN1-S. Indeed, ITSN1-L is important in regulation of exocytosis through activation of Cdc42. 22, 34, 35 However, it is not clear that ITSN1-L possesses all the same activities as ITSN1-S (reviewed in O'Bryan 16 ). For example, the SH3 domains of ITSN1-L make contacts with the DH-PH region suggesting that these interactions may result in steric constraints that interfere with the SH3 domains binding to specific targets. We have not been successful in stably overexpressing ITSN1-L in human NB cells suggesting that elevated levels of ITSN1-L are not compatible with the growth of these cells. Given that ITSN1-L is highly expressed in neurons and poorly expressed in NBs, ITSN1-L may be more important for regulating neuronal differentiation versus oncogenic transformation.
ITSN1's role in NB tumorigenesis is linked to its ability to regulate signaling rather than due to its role in endocytosis. Although ITSN1 regulates clathrin-and caveolin-dependent internalization (reviewed in O'Bryan 16 ), stable silencing of ITSN1 did not affect transferrin uptake consistent with previous findings. 13 Furthermore, overexpression of PI3K-C2b was sufficient to rescue anchorage-independent growth of ITSN1-silenced IMR-5 cells suggesting that the defect in tumor formation by ITSN1-silenced cells is due to impairment in the PI3K-C2b signaling pathway. Indeed, PI3K activation in NBs enhances PKB/AKT activation leading to the stabilization of MYCN levels as a result of decreased GSK-3b phosphorylation of MYCN, which leads to degradation of the oncoprotein.
3 ITSN1 depletion results in reduced basal phosphorylation of AKT in neurons and in NB cells 13 (data not shown) suggesting a defect in PI3K pathway activation in these cells. ITSN1 also regulates the compartmentalized activation of Ras; 21 however, the effects of ITSN1-Ras activation in human NB is not known. Finally, a number of receptor tyrosine kinases (RTKs) such as TrkB and Alk have important roles in NB tumorigenesis. 36 --40 ITSN1 regulates RTK trafficking and PI3K-C2b associates with multiple receptor tyrosine kinases. 41, 42 Thus, future studies on the role of ITSN1-PI3K-C2b in ITSN1 acts as an oncogene in neuroblastomasRTK signaling in NBs may reveal new signaling pathways important for NB tumorigenesis. In conclusion, our findings reveal a novel role for both ITSN1 and PI3K-C2b in NB tumorigenesis providing new insight in the molecular signaling pathways underlying NB tumorigenesis.
MATERIALS AND METHODS
Reagents and cell culture
The polyclonal rabbit anti-ITSN1 antibody has been previously described. 42 Monoclonal antibody against human PI3K-C2b was purchased from BD Transduction Laboratories (Sparks, MD, USA). Antibody to the p110 subunit of Class 1 PI3K (PI3K-C1a) was purchased from Cell Signaling Technologies (Danvers, MA USA). Antibody to b-actin were purchased from Sigma (St Louis, MO, USA). All NB cell lines used in this study were maintained in RPMI with 10% fetal bovine serum at 37 1C in 5% CO 2 and were the kind gifts of Drs Bernard Weissman (University of North Carolina at Chapel Hill) and Naohiko Ikegaki (University of Illinois at Chicago). Puromycin (GIBCO, Grand Island, NY, USA) was used at 1 mg/ml and G418 (GIBCO) was used at 200 mg/ml.
Stable silencing of ITSN1
Phoenix-GP cells were kindly provided by Dr Gary Nolan (Stanford University). These packaging cells were transiently transfected using ITSN1 acts as an oncogene in neuroblastomascalcium phosphate method with 20 mg of vector alone (pSUPER.retro.puro; pSR) or pSR-expressing shRNAs to ITSN1 (sh#1 or #2) along with a plasmid encoding the VSV-G (vesicular stomatitis virus-G) envelope to generate viral particles. On the following day, the media was replaced with fresh media, and NB cells seeded for infection. On day 2 post transfection, conditioned media from the Phoenix-GP cells was collected, filtered, and used to infect NB cells followed by selection in puromycin. Following selection, colonies were pooled to generate a polyclonal cell line, which was used for all subsequent analyses. Western blot analyses of polyclonal cell lines were performed as previously described. 19 The sequences of oligonucleotides used to construct these vectors are as follows: sh#1A: Proliferation assay NB cells (700 per well) were plated on 24-well plates in complete media (RPMI þ 10%FBS plus puromycin) for the indicated number of days. On the indicated day, media was removed and replaced with 100 ml of complete media to which 100 ml of CellTiter Glow (Promega, Madison, WI, USA) was added to the cells. Luminescence was quantified on a Dynex (Chantilly, VA, USA) 96-well microtiter plate luminometer according to the manufacture's instructions.
Soft agar assay
Assays were performed essentially as described. 43 Briefly, 5% (w/v) agar (DIFCO, Detroit, MI, USA) was prepared in distilled water then diluted to 0.5% final concentration with complete media and kept at 60 1C in a water bath. A bottom layer of 0.5% agar was plated in each well of six-well plates to which cells were subsequently plated in a top layer of 0.37% agar cooled at 37 1C. Samples were placed in humidified cell culture incubators at 37 1C for 2-3 weeks after which colonies were stained using 100 ml solution of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (2 mg/ml in H 2 O).
Transferrin internalization assay
Cells (2 Â 10 5 per well) were plated in six-well plates. The following the day, cells were equilibrated in the presence of 2% BSA for 1 h at 37 1C then incubated in the presence of biotinylated transferrin for 15 min at 37 1C. Cells were washed with ice cold PBS, followed by an acid wash (0.2 M NaCl/ 0.2 M acetic acid) on ice for 8 min then lysed and analyzed by western blot using horseradish peroxidase linked to streptavidin as previously described. 13 
Apoptosis assays
Cells were seeded on Ultra-Low attachment plates (Corning, Corning, NY, USA) at a density of 0.5 Â 10 6 cells per well. After 24 h, cells were collected, washed once with PBS and trypsinized (0.25%) for 10 min at 37 1C, washed again with PBS, centrifuged and resuspended in 1 Â binding buffer at a concentration of 1 Â 10 6 cells/ml. 100 ml of the cell suspension (1 Â 10 5 cells) were transferred into a 5 ml culture tube. 5 ml of fluorescein isothiocyanate-conjugated-Annexin V and/or 1 ml of PI were added to the cells. The cells were then incubated for 15 min at RT (25 1C) in the dark followed by addition of 400 ml of 1Â binding buffer to each tube. Apoptosis was then quantified by flow cytometry within one hour.
Xenograft tumor assays
Approximately 10 Â 10 6 cells for each stable NB line were collected in resuspended in Matrigel (BD Bioscience, Bedford, MA, USA) at a 1:1 volume ratio in a total volume of 200 ml. This cell --Matrigel mixture was kept on ice, then injected subcutaneously into the mouse flanks using a 25-G syringe. 
